The Association for the Accreditation of Human Research Protection Programs announced that it has accredited two more organizations: Boise VA Medical Center in Boise, Idaho, and VA Puget Sound Health Care System in Seattle, Wash.
All told, 243 organizations have now earned accreditation, including institutions in 46 states, the District of Columbia, Puerto Rico, Canada, China, India, Korea, and Singapore.
The latest accreditations come as AAHRPP marks 10 years since the issuance of the first accreditation standards in 2002. "Our progress has been remarkable," said Marjorie A. Speers, Ph.D., AAHRPP president and CEO. "A decade ago, accreditation was virtually unheard of. Today, it is synonymous with high-quality research and ethical treatment of research participants."
Speers gives much of the credit for AAHRPP's success to the research enterprise. "Accreditation has taken hold because the research community genuinely cares about protecting participants," she said. "Despite the challenges of the past decade, the research community has stood firm and embraced the rigors of accreditation."
Accreditation is available to US and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. The list of accredited organizations includes community and teaching hospitals; VA facilities, universities; institutional review boards; research institutes and contract research organizations.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.